Otherwise, calcium may deposit in your soft tissues, leading to weaker bones
Patients who might be considered for GLP-1 therapy (within licensed indications) and who may experience secondary benefits for binge eating behaviours include: Individuals with binge eating disorder and type 2 diabetes , where GLP-1 agonists address the primary diabetes indication whilst potentially helping with eating patterns Those with BED and obesity who meet NHS eligibility criteria for weight management medications (as defined by NICE TA875 for semaglutide or TA664 for liraglutide, which are narrower than the marketing authorisation) Patients who have not responded adequately to psychological interventions such as cognitive behavioural therapy (CBT) and who have concurrent metabolic conditions Those experiencing significant food cravings and loss-of-control eating as part of their weight management challenges However, important cautions and considerations apply
Sample Mixing Ratios 5mg Semaglutide + 2mL Bacteriostatic Water: Yields 2.5mg/mL 10mg Semaglutide + 4mL Bacteriostatic Water: Yields 2.5mg/mL Adjust based on your prescribed dose and desired concentration
While human clinical trials remain limited, the existing body of evidence suggests BPC-157 may offer significant benefits for injury recovery, gut health, and tissue regeneration when used under proper medical supervision
If you faint at the sight of a needle, the pill is the clear winner
